One potential biomarker for teratozoospermia identified by in-depth integrative analysis of multiple microarray data

Area of Science:

• Reproductive Biology
• Genomics
• Bioinformatics

Background:

• Teratozoospermia is a significant cause of male infertility, necessitating improved diagnostic tools.
• Assisted reproductive technologies (ART) require accurate biomarkers for patient diagnosis and treatment success prediction.

Purpose of the Study:

• To identify a novel semen biomarker for rapid teratozoospermia diagnosis.
• To assess the potential of identified biomarkers in predicting ART success rates.

Main Methods:

• Differential gene expression analysis of DNA microarray datasets (GSE6872, GSE6967).
• Gene Set Enrichment Analysis (GSEA) for KEGG pathway enrichment.
• Weighted Gene Co-expression Network Analysis (WGCNA) to identify correlated gene modules.
• Cross-dataset validation using GSE6968 and in vitro experiments.

Main Results:

• Identified three differentially expressed genes common to both initial datasets.
• Validated one potential semen biomarker gene with consistent expression trends across datasets and in vitro.
• This biomarker shows promise for teratozoospermia diagnosis.

Conclusions:

• A single potential semen biomarker gene was identified through integrated bioinformatics analysis.
• This biomarker offers a theoretical basis for improved teratozoospermia diagnosis and treatment strategies.
• Further research is warranted to fully establish its clinical utility in male infertility management.